| 促红细胞生成素治疗急性心肌梗死的研究进展 |
| |
| 引用本文： | 刘进军,万志强. 促红细胞生成素治疗急性心肌梗死的研究进展[J]. 心血管病学进展, 2007, 28(3): 474-477 |
| |
| 作者姓名： | 刘进军 万志强 |
| |
| 作者单位： | 蚌埠医学院第一附属医院心内科,安徽,蚌埠,233003 |
| |
| 摘 要： | 促红细胞生成素不仅能够促进红系分化增殖、促进造血,还具有更为重要的细胞保护作用,其受体广泛存在于心血管系统,在心脏的心外膜和心包膜均有表达。促红细胞生成素在心血管系统的作用越来越受到医学界的关注,尤其是促红细胞生成素对急性心肌梗死、缺血/再灌注损伤的心肌保护作用。
|
| 关 键 词： | 促红细胞生成素 心肌梗死 缺血/再灌注损伤 |
| 文章编号： | 1004-3934(2007)03-0474-04 |
| 修稿时间： | 2006-07-13 |
A Study of Erythropoietin in Treatment of Acute Myocardial Infarction |
| |
| LIU Jin-jun,WAN Zhi-qiang. A Study of Erythropoietin in Treatment of Acute Myocardial Infarction[J]. Advances in Cardiovascular Diseases, 2007, 28(3): 474-477 |
| |
| Authors: | LIU Jin-jun WAN Zhi-qiang |
| |
| Affiliation: | Department of Cardiology, The First Affiliated Hosital of Bengbu Medical College, Bengbu 233003, China |
| |
| Abstract: | Erythropoietin can not only promote erythro-system differentiation and generation and haematogenesis,but it is more important to possess cytoprotection,erythropoietin receptor generally reside in cardiovascular system,visceral layer and cardiac pericardium all have erythropoietin receptor.Medical science pay more and more close attention to effect of erythropoietin in cardiovascular system,especially erythropoietin has effect of myocardial preservation in acute myocardial infarction and ischemia-reperfusion injury. |
| |
| Keywords: | erythropoietin myocardial infarction ischemia-reperfusion injury |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
